open access publication

Article, 2023

Efficacy and toxicity of hypofractionated radiation therapy for patients with hematologic malignancies: update on a COVID era ILROG collaborative report

In: Hematological Oncology, ISSN 1099-1069, 0278-0232, Volume 41, S2, Pages 609-610, 10.1002/hon.3164_458

Contributors (16)

Yang, J. [1] Gunther, Jillian Rebecca [2] Hajj, Carla (0000-0001-8774-1845) [3] Ng, Andrea K [4] Brady, Jessica [5] Cheng, S [6] Levis, Mario (0000-0002-7668-3296) [7] Qi, Shu-Nan (0000-0002-0921-8052) [8] Mikhaeel, Nabegh George (0000-0003-0359-0328) [5] Ricardi, Umberto (0000-0003-4406-7621) [7] Illidge, Tim Martin (0000-0003-3191-7324) [9] Turin, A [10] Knafl, Mark K [2] Specht, Lena K (0000-0002-6902-2190) [11] Dabaja, Bouthaina Shbib [2] Yahalom, Joachim (0000-0003-1658-8585) [3]

Affiliations

  1. [1] Washington University in St. Louis
  2. [NORA names: United States; America, North; OECD]
  3. [2] The University of Texas MD Anderson Cancer Center
  4. [NORA names: United States; America, North; OECD]
  5. [3] Memorial Sloan Kettering Cancer Center
  6. [NORA names: United States; America, North; OECD]
  7. [4] Dana-Farber Cancer Institute
  8. [NORA names: United States; America, North; OECD]
  9. [5] Guy's Cancer Centre, linical Oncology and Radiotherapy, London, UK

Keywords

COVID era, collaborative report, efficacy, era, hematologic malignancies, hypofractionated radiation therapy, malignancy, patients, radiation therapy, report, therapy, toxicity